Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 570.82%43.96M | ---- | -61.86%-9.34M | ---- | 91.77%-5.77M | ---- | -181.02%-70.07M | ---- | -159.70%-24.94M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.32%-6.62M | ---- | 5.37%-6.6M | ---- | 14.54%-6.97M | ---- | 15.00%-8.16M | ---- | 23.65%-9.59M |
| Attributable subsidiary (profit) loss | ---- | 24.46%-12.42M | ---- | 20.71%-16.44M | ---- | -345.23%-20.73M | ---- | 18.59%-4.66M | ---- | -188.53%-5.72M |
| Impairment and provisions: | ---- | -44.02%1.37M | ---- | 95.61%2.45M | ---- | -67.34%1.25M | ---- | 380.10%3.84M | ---- | -22.35%799K |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --752K | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -44.02%1.37M | ---- | 95.61%2.45M | ---- | -59.37%1.25M | ---- | 285.98%3.08M | ---- | -22.35%799K |
| Revaluation surplus: | ---- | -154.93%-7.16M | ---- | --13.03M | ---- | ---- | ---- | ---1.42M | ---- | ---- |
| -Other fair value changes | ---- | -154.93%-7.16M | ---- | --13.03M | ---- | ---- | ---- | ---1.42M | ---- | ---- |
| Asset sale loss (gain): | ---- | 1,826.67%289K | ---- | 66.67%15K | ---- | --9K | ---- | ---- | ---- | -98.11%1K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,826.67%289K | ---- | 66.67%15K | ---- | --9K | ---- | ---- | ---- | -98.11%1K |
| Depreciation and amortization: | ---- | -35.94%7.8M | ---- | -3.03%12.17M | ---- | 172.03%12.55M | ---- | -1.07%4.62M | ---- | 13.95%4.67M |
| Financial expense | ---- | -35.37%6M | ---- | 20.77%9.29M | ---- | -10.70%7.69M | ---- | 72.44%8.61M | ---- | -52.09%4.99M |
| Exchange Loss (gain) | ---- | 4.95%742K | ---- | 106.59%707K | ---- | -89.33%-10.73M | ---- | -3,083.16%-5.67M | ---- | 120.28%190K |
| Special items | ---- | 0.00%-466K | ---- | -269.45%-466K | ---- | -98.07%275K | ---- | 3,472.58%14.27M | ---- | -81.55%-423K |
| Operating profit before the change of operating capital | ---- | 593.95%33.5M | ---- | 121.54%4.83M | ---- | 61.77%-22.42M | ---- | -95.32%-58.64M | ---- | -159.94%-30.02M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -77.07%5.91M | ---- | 287.53%25.77M | ---- | -39.93%-13.74M | ---- | -132.21%-9.82M | ---- | 36.76%30.5M |
| Accounts receivable (increase)decrease | ---- | -206.69%-49.82M | ---- | 179.78%46.7M | ---- | -2,650.42%-58.53M | ---- | -119.79%-2.13M | ---- | -92.80%10.75M |
| Accounts payable increase (decrease) | ---- | 106.71%4.5M | ---- | -163.18%-67.09M | ---- | 1,431.86%106.18M | ---- | 90.06%-7.97M | ---- | -128.15%-80.2M |
| Special items for working capital changes | ---- | -299.26%-1.34M | ---- | -67.86%673K | ---- | 363.27%2.09M | ---- | 3,666.67%452K | ---- | -96.75%12K |
| Cash from business operations | ---- | -166.59%-7.25M | ---- | -19.85%10.88M | ---- | 117.38%13.58M | ---- | -13.27%-78.11M | ---- | -136.87%-68.96M |
| Other taxs | ---- | 11.04%-943K | ---- | -52.96%-1.06M | ---- | 89.62%-693K | ---- | 51.11%-6.68M | ---- | -39.10%-13.66M |
| Special items of business | 86.54%36.91M | ---- | 185.83%19.79M | ---- | -174.39%-23.06M | ---- | 351.49%30.99M | ---- | 88.51%-12.32M | ---- |
| Net cash from operations | 86.54%36.91M | -183.38%-8.19M | 185.83%19.79M | -23.76%9.82M | -174.39%-23.06M | 115.20%12.89M | 351.49%30.99M | -2.63%-84.79M | 88.51%-12.32M | -146.62%-82.62M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 698.60%11.4M | 0.38%2.41M | -50.62%1.43M | -30.67%2.4M | -78.43%2.89M | -34.60%3.46M | 174.10%13.4M | 19.61%5.29M | --4.89M | -36.46%4.42M |
| Dividend received - investment | ---- | ---- | ---- | 119.09%19.28M | --14.7M | --8.8M | ---- | ---- | ---- | --22.57M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -47.45%19.25M |
| Decrease in deposits (increase) | 43,765.79%116.68M | -180.03%-19.84M | -99.09%266K | 163.90%24.79M | 124.45%29.27M | -136.44%-38.79M | -6,495.54%-119.71M | 140.81%106.45M | -104.25%-1.82M | 134.52%44.21M |
| Sale of fixed assets | ---- | --2.03M | --15K | ---- | ---- | --80K | ---- | ---- | ---- | --4K |
| Purchase of fixed assets | 64.31%-8.41M | 19.73%-62.56M | 52.55%-23.58M | -177.41%-77.93M | -211.98%-49.68M | -1,264.35%-28.09M | -653.67%-15.93M | 85.09%-2.06M | 65.46%-2.11M | -84.80%-13.81M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---151.45M |
| Recovery of cash from investments | ---- | ---- | ---- | --38.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | 15,486.21%18.08M | ---- | -71.14%116K | ---- | 1.01%402K | ---- | 41.64%398K | ---- | --281K | -75.64%1.15M |
| Net cash from investment operations | 733.22%137.75M | -1,249.26%-77.95M | -799.63%-21.75M | 112.44%6.78M | 98.02%-2.42M | -149.73%-54.54M | -9,917.73%-121.84M | 248.90%109.68M | -96.61%1.24M | 15.53%-73.66M |
| Net cash before financing | 8,983.77%174.66M | -618.73%-86.15M | 92.28%-1.97M | 139.87%16.61M | 71.96%-25.47M | -267.36%-41.65M | -719.77%-90.85M | 115.93%24.89M | 84.33%-11.08M | -273.61%-156.28M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 65.00%330M | -41.26%180M | 23.70%200M | 21.99%306.44M | -29.70%161.69M | 67.47%251.2M | -0.02%230M | 650.00%150M | -7.98%230.06M |
| Refund | 51.90%-101M | -48.75%-280.6M | 7.90%-210M | -14.73%-188.64M | -14.22%-228.02M | -25.35%-164.41M | -198.40%-199.64M | 6.47%-131.16M | 4.43%-66.9M | 59.18%-140.24M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | -76.63%13.1M | ---- | --56.06M | --31.55M | ---- |
| Interest paid - financing | -14.76%-4.25M | 8.19%-9.73M | -56.31%-3.71M | -59.76%-10.59M | 53.73%-2.37M | 22.98%-6.63M | 7.61%-5.12M | -72.44%-8.61M | -138.03%-5.55M | 52.09%-4.99M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 44.00%-39.2M |
| Other items of the financing business | --600K | ---- | ---- | ---- | ---- | ---- | ---- | ---5M | ---- | ---- |
| Net cash from financing operations | -208.81%-104.65M | 9,431.88%39.46M | -144.67%-33.89M | -87.83%414K | 64.00%75.86M | -97.58%3.4M | -57.43%46.26M | 214.03%140.69M | 307.66%108.67M | 125.65%44.8M |
| Effect of rate | ---14K | ---- | ---- | -67.98%815K | 320.03%1.4M | 453.47%2.55M | 17.88%-634K | -2,500.00%-720K | -1,584.62%-772K | -34.78%30K |
| Net Cash | 295.24%70M | -374.27%-46.68M | -171.15%-35.86M | 144.50%17.02M | 213.01%50.39M | -123.10%-38.25M | -145.69%-44.59M | 248.53%165.58M | 179.31%97.59M | -31.70%-111.48M |
| Begining period cash | -18.84%201.08M | 7.76%247.77M | -2.54%247.77M | -13.44%229.93M | -31.68%254.22M | 28.17%265.64M | 79.55%372.11M | -34.97%207.25M | -34.97%207.25M | -20.98%318.7M |
| Cash at the end | 27.92%271.07M | -18.84%201.08M | -30.75%211.91M | 7.76%247.77M | -6.39%306M | -38.21%229.93M | 7.50%326.88M | 79.55%372.11M | 55.37%304.07M | -34.97%207.25M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | --278.78M | ---- | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | --278.78M | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Lixin Dehao Certified Public Accountants Co., Ltd. | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.